Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IMMP |
---|---|---|
09:32 ET | 79792 | 2.0001 |
09:34 ET | 20317 | 1.9963 |
09:36 ET | 17959 | 1.96 |
09:38 ET | 7319 | 1.95 |
09:39 ET | 50409 | 1.815 |
09:41 ET | 23988 | 1.8291 |
09:43 ET | 21491 | 1.807 |
09:45 ET | 32961 | 1.81 |
09:48 ET | 8759 | 1.83 |
09:50 ET | 13085 | 1.82 |
09:52 ET | 20941 | 1.7894 |
09:54 ET | 29894 | 1.75 |
09:56 ET | 7902 | 1.7494 |
09:57 ET | 27321 | 1.745 |
09:59 ET | 13983 | 1.745 |
10:01 ET | 20950 | 1.745 |
10:03 ET | 8338 | 1.735 |
10:06 ET | 19318 | 1.725 |
10:08 ET | 7337 | 1.72 |
10:10 ET | 12177 | 1.725 |
10:12 ET | 19744 | 1.71 |
10:14 ET | 34121 | 1.6997 |
10:15 ET | 10823 | 1.69 |
10:17 ET | 16076 | 1.6986 |
10:19 ET | 855 | 1.695 |
10:21 ET | 13497 | 1.6899 |
10:24 ET | 10909 | 1.68 |
10:26 ET | 7726 | 1.665 |
10:28 ET | 27894 | 1.665 |
10:30 ET | 9266 | 1.664 |
10:32 ET | 9873 | 1.66 |
10:33 ET | 11275 | 1.675 |
10:35 ET | 20833 | 1.66 |
10:37 ET | 3777 | 1.665 |
10:39 ET | 8089 | 1.67 |
10:42 ET | 41629 | 1.6791 |
10:44 ET | 35550 | 1.6999 |
10:46 ET | 76206 | 1.7306 |
10:48 ET | 35866 | 1.75 |
10:50 ET | 70651 | 1.72 |
10:51 ET | 3523 | 1.745 |
10:53 ET | 24397 | 1.7499 |
10:55 ET | 17634 | 1.725 |
10:57 ET | 10421 | 1.725 |
11:00 ET | 3446 | 1.715 |
11:02 ET | 2311 | 1.715 |
11:04 ET | 14519 | 1.73 |
11:06 ET | 3148 | 1.7394 |
11:08 ET | 17278 | 1.7397 |
11:09 ET | 2762 | 1.74 |
11:11 ET | 5587 | 1.735 |
11:13 ET | 16808 | 1.74 |
11:15 ET | 3272 | 1.735 |
11:18 ET | 7537 | 1.735 |
11:20 ET | 5855 | 1.735 |
11:22 ET | 13052 | 1.74 |
11:24 ET | 3361 | 1.7391 |
11:26 ET | 15429 | 1.7391 |
11:27 ET | 2543 | 1.735 |
11:29 ET | 9012 | 1.7391 |
11:31 ET | 29720 | 1.735 |
11:33 ET | 12038 | 1.74 |
11:36 ET | 1325 | 1.7301 |
11:38 ET | 25788 | 1.77 |
11:40 ET | 6266 | 1.7699 |
11:42 ET | 13225 | 1.815 |
11:44 ET | 38191 | 1.805 |
11:45 ET | 21517 | 1.8299 |
11:47 ET | 27365 | 1.82 |
11:49 ET | 2623 | 1.815 |
11:51 ET | 5501 | 1.82 |
11:54 ET | 5920 | 1.8257 |
11:56 ET | 1211 | 1.8207 |
11:58 ET | 4041 | 1.82 |
12:00 ET | 8734 | 1.81 |
12:02 ET | 4719 | 1.81 |
12:03 ET | 16559 | 1.805 |
12:05 ET | 5377 | 1.8085 |
12:07 ET | 11561 | 1.81 |
12:09 ET | 1588 | 1.8098 |
12:12 ET | 7707 | 1.81 |
12:14 ET | 577 | 1.81 |
12:16 ET | 6075 | 1.8199 |
12:18 ET | 975 | 1.81 |
12:20 ET | 12048 | 1.83 |
12:21 ET | 3914 | 1.8207 |
12:23 ET | 3400 | 1.84 |
12:25 ET | 9457 | 1.87 |
12:27 ET | 8498 | 1.8893 |
12:30 ET | 14584 | 1.89 |
12:32 ET | 900 | 1.89 |
12:34 ET | 2424 | 1.8891 |
12:36 ET | 7210 | 1.89 |
12:38 ET | 11773 | 1.895 |
12:39 ET | 10558 | 1.9 |
12:41 ET | 4952 | 1.8999 |
12:43 ET | 10634 | 1.8983 |
12:45 ET | 2052 | 1.8893 |
12:48 ET | 5244 | 1.885 |
12:50 ET | 1302 | 1.89 |
12:52 ET | 3047 | 1.89 |
12:54 ET | 1910 | 1.8899 |
12:56 ET | 1579 | 1.885 |
12:57 ET | 1421 | 1.89 |
12:59 ET | 4105 | 1.885 |
01:01 ET | 2713 | 1.8888 |
01:03 ET | 6006 | 1.8889 |
01:06 ET | 10491 | 1.9 |
01:08 ET | 2606 | 1.885 |
01:10 ET | 4200 | 1.89 |
01:12 ET | 3100 | 1.89 |
01:14 ET | 8127 | 1.8899 |
01:15 ET | 3650 | 1.88 |
01:17 ET | 9039 | 1.9 |
01:19 ET | 16994 | 1.92 |
01:21 ET | 6635 | 1.92 |
01:24 ET | 3858 | 1.93 |
01:26 ET | 1847 | 1.92 |
01:28 ET | 11862 | 1.92 |
01:30 ET | 6750 | 1.91 |
01:32 ET | 5814 | 1.9189 |
01:33 ET | 850 | 1.918 |
01:35 ET | 2267 | 1.91 |
01:37 ET | 1313 | 1.91 |
01:39 ET | 855 | 1.9093 |
01:42 ET | 11313 | 1.905 |
01:44 ET | 3395 | 1.905 |
01:46 ET | 2700 | 1.9 |
01:48 ET | 4609 | 1.8907 |
01:50 ET | 5100 | 1.895 |
01:51 ET | 1672 | 1.892 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Immutep Ltd | 420.0M | -7.3x | --- |
Nautilus Biotechnology Inc | 282.5M | -4.3x | --- |
Inozyme Pharma Inc | 270.3M | -3.3x | --- |
Atea Pharmaceuticals Inc | 288.9M | -1.7x | --- |
Alto Neuroscience Inc | 267.8M | -5.5x | --- |
Black Diamond Therapeutics Inc | 263.8M | -2.7x | --- |
Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $420.0M |
---|---|
Revenue (TTM) | $170.6K |
Shares Outstanding | 145.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.23 |
EPS | $-0.26 |
Book Value | $0.76 |
P/E Ratio | -7.3x |
Price/Sales (TTM) | 2,462.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -18,287.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.